Neurology

Around the Helix: Gene and Cell Therapy Company Updates - January 19, 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in gene and cell therapies.

FDA Extends BLA Review for bluebird bio’s β-Thalassemia and CALD Gene Therapies

Eli-cel remains on clinical hold in cerebral adrenoleukodystrophy after a report of persistent anemia.

GeneTherapyLive’s Weekly Rewind – January 14, 2022

Review top news and interview highlights from the week ending January 14, 2022.